Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)
about
Effects of hormone therapy on cognition and moodPostmenopausal hormone therapy and cognitionEffects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective StudyPrevention of cognitive impairment in the midlife womenProgesterone in Peri- and Postmenopause: A Review.Estradiol and cognitive function: past, present and future.Long-term consequences of estrogens administered in midlife on female cognitive agingInhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.Sex and the development of Alzheimer's disease.Mitochondrial and sex steroid hormone crosstalk during aging.Surgical menopause and cognitive decline.Steroid hormones, receptors, and perceptual and cognitive sex differences in the visual system.Hormone replacement therapy in the treatment of perimenopausal depression.Prevention and management of stroke in women.Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).Physiology, production and action of progesterone.Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics.Gender differences in neurologic emergencies part I: a consensus summary and research agenda on cerebrovascular disease.Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.Aortic hemodynamics in postmenopausal women following cessation of hormone therapy.
P2860
Q26865143-EC9F55F9-6FF3-4451-AD27-9B5B97C0BB27Q27008086-950B3A8F-AE0F-43EE-B215-16F44EE9B388Q28547748-AA5071C2-36FD-4315-8D20-59F9B4596304Q34479407-2FAB62C4-5411-44F8-B0D0-B422C4FD88D6Q34576608-711680D2-9D99-4789-856D-F3567E5F7D24Q35054370-A497D3C1-E508-49AF-A30A-6CEFF8AF9806Q35616166-7566DB46-288A-4955-92F2-9BC190CC13B2Q36080001-6800977A-786C-46B3-9036-7C21AB66F2F7Q36807581-C2815821-DEDF-44BA-B614-DBD2A39AA4D8Q37432182-51793498-9585-498E-83E1-8E3060AF7037Q37580129-5FBC1C24-22F2-491D-A272-F6E5C1C80333Q38185755-BC450E9A-D515-4EE4-8F2E-431E8E565F87Q38242935-96C87C22-DB37-4964-AE34-922EC1492E99Q38259467-A4B847FC-5B5B-440E-9080-9BB471718B0BQ38369639-874C1FF4-7CD7-4435-8D4D-82299D516D2FQ38371598-E171F0E1-0164-4929-963F-F1D22EC6538BQ38584393-4347EA45-21C6-441A-B013-3CB93CFA0EE6Q38612740-536F1D5C-3162-4846-B5DC-CA5E59C706FFQ38719665-F05A6C45-2525-491D-8778-76797A9B6770Q38983318-77B924CC-C466-44E7-9EAC-65C2F609A2B0Q39094428-3AF3F767-7E50-4AF7-84F6-4BEECE932CC5Q39165361-555F6D75-0489-441A-9FA6-16C76894E3FAQ42634564-CB7AA55E-2815-417D-BF70-3C18E99C750FQ47170478-D7FDEF6E-7D0E-4991-81DC-F2DFFFC595F2
P2860
Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationale and design of the Kr ...... ffective sub study (KEEPS Cog)
@en
Rationale and design of the Kronos Early Estrogen Prevention Study
@nl
type
label
Rationale and design of the Kr ...... ffective sub study (KEEPS Cog)
@en
Rationale and design of the Kronos Early Estrogen Prevention Study
@nl
prefLabel
Rationale and design of the Kr ...... ffective sub study (KEEPS Cog)
@en
Rationale and design of the Kronos Early Estrogen Prevention Study
@nl
P2093
P2860
P1433
P1476
Rationale and design of the Kr ...... ffective sub study (KEEPS Cog)
@en
P2093
Carey E Gleason
Sanjay Asthana
Virginia M Miller
Whitney Wharton
P2860
P356
10.1016/J.BRAINRES.2013.04.011
P407
P577
2013-04-17T00:00:00Z